MENU
IKNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ikena Oncology (IKNA) Ownership - Who owns Ikena Oncology?

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network... Show more

Profile

Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
62.98M
P/E Ratio
N/A
Total Cash
114.05M
Projected Growth
N/A
Total Debt
6.61M
Revenue
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash/Share
2.36
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

IKNA
Capitalization
63M
P/E Ratio
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash
114M
Total Cash/Share
2.36
Total Debt
6.61M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
118M
P/B Ratio
0.55
Cash Flow
N/A
Earnings
-0.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
48K
Current Ratio
13.31
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-47.91M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.47
Shares Held By Institutions
40.8M
Shares Outstanding - Current
48.3M
Total Liabilities
12.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.427
View a ticker or compare two or three
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com